Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited

Author： Calhoun Elizabeth A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.8, 2005-01, pp. : 767-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia

By Esser M.   Brunner H.  

PharmacoEconomics, Vol. 21, Iss. 18, 2003-01 ,pp. : 1295-1313

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial

By Bojke Laura  

PharmacoEconomics, Vol. 24, Iss. 5, 2006-01 ,pp. : 443-452

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) does not appear to have any additional benefit in patients with acute myeloid leukaemia (AML) receiving chemotherapy

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

By Griffiths Robert I.   Barron Richard L.  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 103-118

Adis International

Access to resources Recommend Favorite

The Role of Colony-Stimulating Factors and Granulocyte Transfusion in Treatment Options for Neutropenia in Children with Cancer

By Liang D-C.  

Pediatric Drugs, Vol. 5, Iss. 10, 2003-01 ,pp. : 673-684

Adis International

Access to resources Recommend Favorite